News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Conference News THT 2025 AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF Todd Neale February 13, 2025
News Daily News Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF Todd Neale September 20, 2024
News Conference News ESC Heart Failure 2024 Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF Michael O'Riordan May 13, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Conference News ESC 2022 No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE Shelley Wood August 26, 2022
News Daily News AHA Urges More Home-Based Dialysis in Advanced Kidney Failure Michael O'Riordan August 18, 2022
News Daily News Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis Caitlin E. Cox May 03, 2022
News Daily News CVD Hospitalizations Spiked in Aftermath of 2020 US Election Michael O'Riordan April 22, 2022
News Daily News Revascularization’s Benefits in HFrEF Linked to Gains in LV Function Caitlin E. Cox April 15, 2022
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021